SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3bcn'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1STF_E_CCSE25_0
(PAPAIN
STEFIN B (CYSTATIN
B))		 3bcn ERVATAMIN-A
(Tabernaemontana
divaricata) 		6 / 10 GLN A  19
GLY A  23
SER A  24
TRP A  26
PHE A  28
HIS A 157
 E64  A 214 (-3.9A)
E64  A 214 (-2.5A)
None
E64  A 214 (-4.8A)
None
E64  A 214 (-4.3A)
 0.28A 1stfE-3bcnA:
22.8
1stfI-3bcnA:
undetectable		 1stfE-3bcnA:
50.23
1stfI-3bcnA:
18.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1STF_E_CCSE25_0
(PAPAIN
STEFIN B (CYSTATIN
B))		 3bcn ERVATAMIN-A
(Tabernaemontana
divaricata) 		6 / 10 GLN A  19
GLY A  23
TRP A  26
PHE A  28
SER A  29
HIS A 157
 E64  A 214 (-3.9A)
E64  A 214 (-2.5A)
E64  A 214 (-4.8A)
None
None
E64  A 214 (-4.3A)
 0.62A 1stfE-3bcnA:
22.8
1stfI-3bcnA:
undetectable		 1stfE-3bcnA:
50.23
1stfI-3bcnA:
18.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QBN_A_CAMA442_0
(CYTOCHROME P450-CAM)		 3bcn ERVATAMIN-A
(Tabernaemontana
divaricata) 		4 / 7 TYR A  72
THR A  33
VAL A 130
VAL A 111
 None
 1.04A 2qbnA-3bcnA:
undetectable		 2qbnA-3bcnA:
18.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2R2V_C_ACTC36_0
(GCN4 LEUCINE ZIPPER)		 3bcn ERVATAMIN-A
(Tabernaemontana
divaricata) 		5 / 10 SER A  57
ALA A  71
ASN A  60
ALA A  27
TYR A  74
 None
 1.34A 2r2vC-3bcnA:
undetectable
2r2vF-3bcnA:
undetectable
2r2vG-3bcnA:
undetectable		 2r2vC-3bcnA:
12.37
2r2vF-3bcnA:
12.37
2r2vG-3bcnA:
12.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZT7_A_GLYA1300_0
(GLYCYL-TRNA
SYNTHETASE)		 3bcn ERVATAMIN-A
(Tabernaemontana
divaricata) 		4 / 7 GLU A  35
ARG A 172
GLU A  50
GLU A  84
 None
 1.26A 2zt7A-3bcnA:
undetectable		 2zt7A-3bcnA:
15.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AI8_A_HNQA255_1
(CATHEPSIN B)		 3bcn ERVATAMIN-A
(Tabernaemontana
divaricata) 		4 / 7 GLN A  19
GLY A  23
HIS A 157
TRP A 175
 E64  A 214 (-3.9A)
E64  A 214 (-2.5A)
E64  A 214 (-4.3A)
None
 0.49A 3ai8A-3bcnA:
26.0		 3ai8A-3bcnA:
28.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3S53_B_017B203_1
(PROTEASE)		 3bcn ERVATAMIN-A
(Tabernaemontana
divaricata) 		4 / 5 PRO A  15
LYS A  17
ARG A 177
GLY A 176
 None
 1.23A 3s53B-3bcnA:
undetectable		 3s53B-3bcnA:
18.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KR3_A_GLYA701_0
(GLYCINE--TRNA LIGASE)		 3bcn ERVATAMIN-A
(Tabernaemontana
divaricata) 		4 / 6 GLU A  35
ARG A 172
GLU A  50
GLU A  84
 None
 1.23A 4kr3A-3bcnA:
undetectable		 4kr3A-3bcnA:
15.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4OU1_A_BEZA302_0
(RETRO-ALDOLASE,
DESIGN RA114)		 3bcn ERVATAMIN-A
(Tabernaemontana
divaricata) 		4 / 8 ILE A  81
LYS A 101
ILE A  75
ASN A  78
 None
 0.92A 4ou1A-3bcnA:
undetectable		 4ou1A-3bcnA:
19.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5IK1_A_CAMA503_0
(CAMPHOR
5-MONOOXYGENASE)		 3bcn ERVATAMIN-A
(Tabernaemontana
divaricata) 		4 / 7 VAL A 102
ASP A  82
ILE A  81
VAL A 103
 None
 0.80A 5ik1A-3bcnA:
undetectable		 5ik1A-3bcnA:
18.16